Thursday, 6 June 2019

Reuters Health Report: Will Europe's clampdown on faulty medical devices hurt patients?

Reuters.com Newsletter

Will Europe's clampdown on faulty medical devices hurt patients?

When a Californian company founded by a U.S. veteran wounded in Afghanistan sought to register a new medical device this year, it turned to Europe before the United States. The European approvals system had long been quicker, the company said, but the introduction of new rules is changing all that.

AstraZeneca's blood cancer drug meets main goal in late-stage trial

AstraZeneca Plc said on Thursday its blood cancer drug met the main goal of a final stage trial, taking the treatment one step closer to a marketing approval as the drugmaker seeks to bolster its oncology portfolio.

Israel's Pitango launches $150 million health technology fund

Israel's Pitango Venture Capital said on Thursday it was launching a fund that will reach $150 million to invest in health technology.

Insys to pay $225 million, plead guilty in U.S. over opioid kickbacks

Insys Therapeutics Inc agreed to pay $225 million and an operating unit will plead guilty to fraud to settle probes into their payment of kickbacks to induce doctors to prescribe highly addictive opioids, the U.S. Department of Justice said on Wednesday.

Trump administration moves to end U.S. research using fetal tissue from abortions

The Trump administration on Wednesday said it would end scientific research at the National Institutes of Health that relies on fetal tissue from elective abortions, and would accelerate efforts to find alternatives for such research, a move welcomed by anti-abortion groups.

Middle schools can help prevent teen dating violence

(Reuters Health) - Middle schools that offer a comprehensive dating violence prevention program in every grade may have fewer youth involved in abusive relationships, a U.S. study suggests.

U.S. soldiers have worse heart health than civilians

(Reuters Health) - U.S. soldiers are more likely to have poor heart health than civilians of similar ages, a new study finds.

Takeda scraps late-stage amyloidosis study

Takeda Pharmaceutical Co Ltd said on Wednesday it would discontinue a late-stage study testing its experimental treatment for amyloidosis, as it did not meet the first of two main goals.

U.S. records 1,000th case of measles, officials blame misinformation for outbreak

The United States has recorded 1,001 measles cases so far this year in the worst outbreak of the highly contagious disease in more than a quarter-century, federal health officials said on Wednesday as they issued a new plea for parents to vaccinate their children.

Wildfire smoke worse for kids' health than prescribed burns

(Reuters Health) - Children who are exposed to smoke from wildfires may experience a greater health impact than those exposed to smoke from prescribed controlled burns, according to a small study in northern California.

Teen boys' eating disorders may focus on muscles, not weight loss

(Reuters Health) - Many people may mistakenly assume teen boys are not prone to eating disorders because their symptoms are different from what's typically seen in girls and their focus is on building muscle rather than becoming impossibly thin, doctors warn.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS